Given AD pathology is associated with reactive gliosis, inflammatory environments within the brain produce proinflammatory cytokines, increase amyloid precursor protein (APP) expression, and promote Amyloid β (Aβ) deposits in the brain [47]. This evidence concerns the gene APP and Alzheimer disease.